Repurposing the CRISPR-Cas9 System for Targeted Chromatin O-linked β-N-acetylglucosamine Editing
Matthew P. Parker(University of Kansas Medical Center), Chad Slawson(University of Kansas Medical Center)
Cited by 1
Related Papers
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
|Trends in Biochemical Sciences|2010|341
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
|Nature Medicine|2025|85
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases
|Nature Medicine|2025|56
O-GlcNAc homeostasis contributes to cell fate decisions during hematopoiesis
|Journal of Biological Chemistry|2018|55
O-GlcNAc regulates the mitochondrial integrated stress response by regulating ATF4
|Frontiers in Aging Neuroscience|2023|19